{
  "ConceptSets": [
    {
      "id": 0,
      "name": "COMT Inhibitors",
      "expression": {
        "items": [
          {
            "concept": {
              "CONCEPT_CLASS_ID": "ATC 5th",
              "CONCEPT_CODE": "N04BA03",
              "CONCEPT_ID": 21604466,
              "CONCEPT_NAME": "levodopa, decarboxylase inhibitor and COMT inhibitor; oral",
              "DOMAIN_ID": "Drug",
              "INVALID_REASON": "V",
              "INVALID_REASON_CAPTION": "Valid",
              "STANDARD_CONCEPT": "C",
              "STANDARD_CONCEPT_CAPTION": "Classification",
              "VOCABULARY_ID": "ATC"
            },
            "includeDescendants": true
          }
        ]
      }
    }
  ],
  "PrimaryCriteria": {
    "CriteriaList": [
      {
        "DrugExposure": {
          "CodesetId": 0,
          "OccurrenceStartDate": {
            "Value": "2008-01-01",
            "Op": "gte"
          },
          "OccurrenceEndDate": {
            "Value": "2021-12-31",
            "Op": "lte"
          }
        }
      }
    ],
    "ObservationWindow": {
      "PriorDays": 0,
      "PostDays": 0
    },
    "PrimaryCriteriaLimit": {
      "Type": "All"
    }
  },
  "QualifiedLimit": {
    "Type": "First"
  },
  "ExpressionLimit": {
    "Type": "First"
  },
  "InclusionRules": [],
  "EndStrategy": {
    "CustomEra": {
      "DrugCodesetId": 0,
      "GapDays": 30,
      "Offset": 0
    }
  },
  "CensoringCriteria": [],
  "CollapseSettings": {
    "CollapseType": "ERA",
    "EraPad": 0
  },
  "CensorWindow": {},
  "cdmVersionRange": ">=5.0.0"
}